|
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
5.095e-28 |
1.00
|
| CAC1B_RAT |
Cacna1b |
Voltage-dependent N-type calcium channel subunit alpha-1B |
4.958e-110 |
0.55
|
| CACB1_RAT |
Cacnb1 |
Voltage-dependent L-type calcium channel subunit beta-1 |
3.196e-98 |
0.55
|
| CA2D2_RAT |
Cacna2d2 |
Voltage-dependent calcium channel subunit alpha-2/delta-2 |
2.435e-90 |
0.55
|
| CACB1_HUMAN |
CACNB1 |
Voltage-dependent L-type calcium channel subunit beta-1 |
2.435e-90 |
0.55
|
| CAC1A_HUMAN |
CACNA1A |
Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
9.472e-82 |
0.55
|
| CA2D1_RAT |
Cacna2d1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 |
8.033e-70 |
0.53
|
| DRD4_RAT |
Drd4 |
D(4) dopamine receptor |
1.273e-69 |
0.40
|
| SC6A3_RAT |
Slc6a3 |
Sodium-dependent dopamine transporter |
2.581e-61 |
0.43
|
| SC6A4_RAT |
Slc6a4 |
Sodium-dependent serotonin transporter |
1.706e-52 |
0.45
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
1.936e-51 |
0.55
|
| SC6A1_RAT |
Slc6a1 |
Sodium- and chloride-dependent GABA transporter 1 |
5.371e-49 |
0.41
|
| NMUR1_HUMAN |
NMUR1 |
Neuromedin-U receptor 1 |
1.653e-47 |
0.39
|
| PA24A_HUMAN |
PLA2G4A |
Cytosolic phospholipase A2 |
5.484e-46 |
0.34
|
| NMUR2_HUMAN |
NMUR2 |
Neuromedin-U receptor 2 |
4.867e-44 |
0.39
|
| 5HT7R_HUMAN |
HTR7 |
5-hydroxytryptamine receptor 7 |
4.162e-42 |
0.44
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
5.12e-41 |
0.44
|
| DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
4.541e-40 |
0.74
|
| CCR1_HUMAN |
CCR1 |
C-C chemokine receptor type 1 |
8.295e-37 |
0.40
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
1.415e-36 |
0.55
|
| SCN2A_RAT |
Scn2a |
Sodium channel protein type 2 subunit alpha |
1.144e-35 |
0.37
|
| O19067_PIG |
|
N-methyl-D-aspartate receptor |
1.377e-35 |
0.28
|
| TYRP1_MOUSE |
Tyrp1 |
5,6-dihydroxyindole-2-carboxylic acid oxidase |
4.217e-35 |
0.29
|
| 5HT1A_HUMAN |
HTR1A |
5-hydroxytryptamine receptor 1A |
2.006e-34 |
0.45
|
| DRD3_HUMAN |
DRD3 |
D(3) dopamine receptor |
2.471e-34 |
0.62
|
| 5HT2A_RAT |
Htr2a |
5-hydroxytryptamine receptor 2A |
4.274e-33 |
0.55
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
6.238e-32 |
0.46
|
| NK2R_BOVIN |
TACR2 |
Substance-K receptor |
5.36e-31 |
0.31
|
| HRH3_CAVPO |
HRH3 |
Histamine H3 receptor |
1.042e-30 |
0.36
|
| PI2R_HUMAN |
PTGIR |
Prostacyclin receptor |
1.677e-30 |
0.41
|
| US28_HCMVA |
US28 |
G-protein coupled receptor homolog US28 |
5.397e-27 |
0.40
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
8.757e-26 |
0.41
|
| CCR5_HUMAN |
CCR5 |
C-C chemokine receptor type 5 |
3.404e-25 |
0.40
|
| TYTR_TRYBB |
TPR |
Trypanothione reductase |
1.157e-24 |
0.34
|
| Q6A2E2_AEDAE |
ace-1 |
Acetylcholinesterase |
8.657e-24 |
0.29
|
| ZN664_CAVPO |
ZNF664 |
Zinc finger protein 664 |
1.926e-23 |
0.29
|
| SC6A3_HUMAN |
SLC6A3 |
Sodium-dependent dopamine transporter |
2.058e-23 |
0.43
|
| SC6A4_HUMAN |
SLC6A4 |
Sodium-dependent serotonin transporter |
3.945e-23 |
0.43
|
| DRD5_HUMAN |
DRD5 |
D(1B) dopamine receptor |
4.042e-23 |
0.35
|
| PCP_HUMAN |
PRCP |
Lysosomal Pro-X carboxypeptidase |
4.877e-23 |
0.40
|
| Q63380_RAT |
NET |
Transporter |
2.078e-22 |
0.36
|
| SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
2.463e-22 |
0.41
|
| OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
5.456e-22 |
0.50
|
| HRH1_CAVPO |
HRH1 |
Histamine H1 receptor |
1.005e-21 |
0.42
|
| 5HT2A_HUMAN |
HTR2A |
5-hydroxytryptamine receptor 2A |
2.925e-21 |
0.74
|
| Q56D28_CAVPO |
CRTH2 |
Chemoattractant receptor-homologous molecule expressed on Th2 cells |
3.935e-21 |
0.36
|
| HRH2_HUMAN |
HRH2 |
Histamine H2 receptor |
4.225e-20 |
0.35
|
| MGLL_MOUSE |
Mgll |
Monoglyceride lipase |
5.447e-20 |
0.43
|
| PCP_MOUSE |
Prcp |
Lysosomal Pro-X carboxypeptidase |
1.97e-19 |
0.40
|
| SC6A1_MOUSE |
Slc6a1 |
Sodium- and chloride-dependent GABA transporter 1 |
2.63e-19 |
0.38
|
| ADA1B_RAT |
Adra1b |
Alpha-1B adrenergic receptor |
3.397e-19 |
0.41
|
| GP139_HUMAN |
GPR139 |
Probable G-protein coupled receptor 139 |
1.883e-18 |
0.32
|
| CP2D6_HUMAN |
CYP2D6 |
Cytochrome P450 2D6 |
3.586e-18 |
0.74
|
| DRD1_PIG |
DRD1 |
D(1A) dopamine receptor |
1.11e-16 |
0.32
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
1.11e-16 |
0.48
|
| PD2R2_HUMAN |
PTGDR2 |
Prostaglandin D2 receptor 2 |
1.11e-16 |
0.36
|
| PI2R_RAT |
Ptgir |
Prostacyclin receptor |
3.331e-16 |
0.35
|
| PA_I000X |
PA |
Polymerase acidic protein |
6.661e-16 |
0.30
|
| Q9WTR4_RAT |
Slc6a2 |
Transporter |
3.331e-15 |
0.38
|
| H10_HUMAN |
H1-0 |
Histone H1.0 |
3.442e-15 |
0.29
|
| HRH3_HUMAN |
HRH3 |
Histamine H3 receptor |
4.663e-15 |
0.36
|
| MGLL_RAT |
Mgll |
Monoglyceride lipase |
5.107e-15 |
0.36
|
| LKHA4_HUMAN |
LTA4H |
Leukotriene A-4 hydrolase |
5.884e-15 |
0.38
|
| Q8HY88_BOVIN |
KCNK2 |
Potassium channel subfamily K member 2 |
1.166e-14 |
0.36
|
| DRD1_HUMAN |
DRD1 |
D(1A) dopamine receptor |
2.331e-14 |
0.37
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
2.398e-14 |
0.46
|
| DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
4.607e-14 |
0.38
|
| SC6A2_HUMAN |
SLC6A2 |
Sodium-dependent noradrenaline transporter |
5.596e-14 |
0.40
|
| NK2R_RAT |
Tacr2 |
Substance-K receptor |
1.458e-13 |
0.31
|
| SL9A3_RAT |
Slc9a3 |
Sodium/hydrogen exchanger 3 |
1.472e-13 |
0.30
|
| ACES_ELEEL |
ache |
Acetylcholinesterase |
2.034e-13 |
0.43
|
| 5HT2C_RAT |
Htr2c |
5-hydroxytryptamine receptor 2C |
3.11e-13 |
0.55
|
| NK2R_HUMAN |
TACR2 |
Substance-K receptor |
8.368e-13 |
0.32
|
| SHIP2_HUMAN |
INPPL1 |
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 |
8.444e-13 |
0.31
|
| MAP11_HUMAN |
METAP1 |
Methionine aminopeptidase 1 |
1.112e-12 |
0.30
|
| DRD3_RAT |
Drd3 |
D(3) dopamine receptor |
1.705e-12 |
0.33
|
| FABPH_HUMAN |
FABP3 |
Fatty acid-binding protein, heart |
1.832e-12 |
0.30
|
| PDR5_YEAST |
PDR5 |
Pleiotropic ABC efflux transporter of multiple drugs |
2.162e-12 |
0.30
|
| FAAH1_HUMAN |
FAAH |
Fatty-acid amide hydrolase 1 |
2.779e-12 |
0.36
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
5.336e-12 |
0.41
|
| CA2D1_HUMAN |
CACNA2D1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 |
5.806e-12 |
0.55
|
| S6A12_MOUSE |
Slc6a12 |
Sodium- and chloride-dependent betaine transporter |
6.161e-12 |
0.32
|
| CNR1_RAT |
Cnr1 |
Cannabinoid receptor 1 |
6.543e-12 |
0.43
|
| CD69_HUMAN |
CD69 |
Early activation antigen CD69 |
7.616e-12 |
0.29
|
| CNR1_HUMAN |
CNR1 |
Cannabinoid receptor 1 |
7.791e-12 |
0.43
|
| TRPM2_HUMAN |
TRPM2 |
Transient receptor potential cation channel subfamily M member 2 |
8.017e-12 |
0.29
|
| ADA1A_HUMAN |
ADRA1A |
Alpha-1A adrenergic receptor |
8.629e-12 |
0.39
|
| MC4R_HUMAN |
MC4R |
Melanocortin receptor 4 |
1.287e-11 |
0.40
|
| SC6A4_MOUSE |
Slc6a4 |
Sodium-dependent serotonin transporter |
1.388e-11 |
0.36
|
| CALM_BOVIN |
CALM |
Calmodulin |
1.754e-11 |
0.31
|
| EBP_CAVPO |
EBP |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase |
3.343e-11 |
0.32
|
| DHCR7_HUMAN |
DHCR7 |
7-dehydrocholesterol reductase |
7.435e-11 |
0.32
|
| MGLL_HUMAN |
MGLL |
Monoglyceride lipase |
9.299e-11 |
0.36
|
| UR2R_HUMAN |
UTS2R |
Urotensin-2 receptor |
1.43e-10 |
0.42
|
| 5HT2C_HUMAN |
HTR2C |
5-hydroxytryptamine receptor 2C |
1.554e-10 |
0.41
|
| SGMR2_RAT |
Tmem97 |
Sigma intracellular receptor 2 |
2.011e-10 |
0.32
|
| O31048_PORGN |
DPP IV |
Dipeptidyl peptidase IV |
2.055e-10 |
0.48
|
| KCNA5_HUMAN |
KCNA5 |
Potassium voltage-gated channel subfamily A member 5 |
2.57e-10 |
0.45
|
| SGMR1_RAT |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
3.561e-10 |
0.36
|
| INHA_MYCTU |
inhA |
Enoyl-[acyl-carrier-protein] reductase [NADH] |
4.2e-10 |
0.43
|
| SGMR2_HUMAN |
TMEM97 |
Sigma intracellular receptor 2 |
4.942e-10 |
0.34
|
| LOX5_HUMAN |
ALOX5 |
Arachidonate 5-lipoxygenase |
5.725e-10 |
0.52
|
| NOS2_MOUSE |
Nos2 |
Nitric oxide synthase, inducible |
8.26e-10 |
0.32
|
| ADA1B_HUMAN |
ADRA1B |
Alpha-1B adrenergic receptor |
9.369e-10 |
0.48
|
| SC6A1_HUMAN |
SLC6A1 |
Sodium- and chloride-dependent GABA transporter 1 |
9.404e-10 |
0.32
|
| ADA1A_RAT |
Adra1a |
Alpha-1A adrenergic receptor |
1.185e-09 |
0.40
|
| GABR2_RAT |
Gabbr2 |
Gamma-aminobutyric acid type B receptor subunit 2 |
1.547e-09 |
0.33
|
| MCHR1_RAT |
Mchr1 |
Melanin-concentrating hormone receptor 1 |
2.231e-09 |
0.32
|
| KCNK2_HUMAN |
KCNK2 |
Potassium channel subfamily K member 2 |
3.108e-09 |
0.29
|
| O31272_9GAMM |
imiS |
Beta-lactamase |
3.598e-09 |
0.29
|
| 5HT7R_RAT |
Htr7 |
5-hydroxytryptamine receptor 7 |
3.749e-09 |
0.30
|
| 5HT4R_RAT |
Htr4 |
5-hydroxytryptamine receptor 4 |
5.767e-09 |
0.38
|
| MRP2_HUMAN |
ABCC2 |
Canalicular multispecific organic anion transporter 1 |
7.167e-09 |
0.33
|
| AP2S1_RAT |
Ap2s1 |
AP-2 complex subunit sigma |
1.153e-08 |
0.29
|
| Q6L5J4_HUMAN |
FPRL2 |
FML2_HUMAN |
1.253e-08 |
0.32
|
| S6A13_MOUSE |
Slc6a13 |
Sodium- and chloride-dependent GABA transporter 2 |
1.613e-08 |
0.32
|
| 5HT2B_HUMAN |
HTR2B |
5-hydroxytryptamine receptor 2B |
1.641e-08 |
0.41
|
| MEP50_HUMAN |
WDR77 |
Methylosome protein 50 |
1.908e-08 |
0.34
|
| ANM5_HUMAN |
PRMT5 |
Protein arginine N-methyltransferase 5 |
2.331e-08 |
0.34
|
| NK1R_HUMAN |
TACR1 |
Substance-P receptor |
2.487e-08 |
0.51
|
| MDR1_HUMAN |
ABCB1 |
ATP-dependent translocase ABCB1 |
3.217e-08 |
0.39
|
| DRD3_CHLAE |
DRD3 |
D(3) dopamine receptor |
3.505e-08 |
0.29
|
| WNK1_HUMAN |
WNK1 |
Serine/threonine-protein kinase WNK1 |
3.548e-08 |
0.29
|
| ADA2A_RAT |
Adra2a |
Alpha-2A adrenergic receptor |
4.755e-08 |
0.29
|
| OPRD_RAT |
Oprd1 |
Delta-type opioid receptor |
7.79e-08 |
0.50
|
| RCE1_YEAST |
RCE1 |
CAAX prenyl protease 2 |
1.203e-07 |
0.41
|
| 5HT1A_MOUSE |
Htr1a |
5-hydroxytryptamine receptor 1A |
1.64e-07 |
0.30
|
| ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
1.729e-07 |
0.41
|
| CASR_HUMAN |
CASR |
Extracellular calcium-sensing receptor |
2.156e-07 |
0.33
|
| ADA2B_HUMAN |
ADRA2B |
Alpha-2B adrenergic receptor |
2.406e-07 |
0.40
|
| SC6A3_MOUSE |
Slc6a3 |
Sodium-dependent dopamine transporter |
2.407e-07 |
0.36
|
| CCR3_HUMAN |
CCR3 |
C-C chemokine receptor type 3 |
2.455e-07 |
0.37
|
| PA_I34A1 |
PA |
Polymerase acidic protein |
2.471e-07 |
0.30
|
| FABP4_HUMAN |
FABP4 |
Fatty acid-binding protein, adipocyte |
3.151e-07 |
0.31
|
| GABR1_RAT |
Gabbr1 |
Gamma-aminobutyric acid type B receptor subunit 1 |
4.324e-07 |
0.33
|
| DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
4.598e-07 |
0.30
|
| SCN4A_HUMAN |
SCN4A |
Sodium channel protein type 4 subunit alpha |
6.622e-07 |
0.30
|
| GABR2_HUMAN |
GABBR2 |
Gamma-aminobutyric acid type B receptor subunit 2 |
7.828e-07 |
0.33
|
| GP183_HUMAN |
GPR183 |
G-protein coupled receptor 183 |
7.94e-07 |
0.34
|
| PD2R2_MOUSE |
Ptgdr2 |
Prostaglandin D2 receptor 2 |
1.09e-06 |
0.30
|
| B2LA1_MOUSE |
Bcl2a1 |
Bcl-2-related protein A1 |
1.203e-06 |
0.31
|
| GABR1_HUMAN |
GABBR1 |
Gamma-aminobutyric acid type B receptor subunit 1 |
1.288e-06 |
0.33
|
| CA2D1_MOUSE |
Cacna2d1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 |
1.656e-06 |
0.31
|
| ACM5_HUMAN |
CHRM5 |
Muscarinic acetylcholine receptor M5 |
1.659e-06 |
0.41
|
| FPR2_HUMAN |
FPR2 |
N-formyl peptide receptor 2 |
1.692e-06 |
0.32
|
| ACM1_RAT |
Chrm1 |
Muscarinic acetylcholine receptor M1 |
1.736e-06 |
0.33
|
| 5HT2A_PIG |
HTR2A |
5-hydroxytryptamine receptor 2A |
1.905e-06 |
0.32
|
| SL9A3_HUMAN |
SLC9A3 |
Sodium/hydrogen exchanger 3 |
2.094e-06 |
0.30
|
| PPARA_HUMAN |
PPARA |
Peroxisome proliferator-activated receptor alpha |
2.112e-06 |
0.33
|
| SENP1_HUMAN |
SENP1 |
Sentrin-specific protease 1 |
2.32e-06 |
0.29
|
| ADA2A_HUMAN |
ADRA2A |
Alpha-2A adrenergic receptor |
2.474e-06 |
0.41
|
| ACHP_LYMST |
|
Acetylcholine-binding protein |
2.476e-06 |
0.34
|
| GP183_MOUSE |
Gpr183 |
G-protein coupled receptor 183 |
2.907e-06 |
0.34
|
| ADA2C_HUMAN |
ADRA2C |
Alpha-2C adrenergic receptor |
2.948e-06 |
0.40
|
| DCNL1_HUMAN |
DCUN1D1 |
DCN1-like protein 1 |
3.432e-06 |
0.30
|
| 5HT4R_HUMAN |
HTR4 |
5-hydroxytryptamine receptor 4 |
4.032e-06 |
0.32
|
| CAC1C_CAVPO |
CACNA1C |
Voltage-dependent L-type calcium channel subunit alpha-1C |
4.295e-06 |
0.36
|
| HCN1_HUMAN |
HCN1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 |
7.581e-06 |
0.29
|